Institutional & Family Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History

Institutional & Family Asset Management’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$166	Hold	50	–	–	﹤0.01%	732
2024 Q1	$164	Hold	50	–	–	﹤0.01%	720
2023 Q4	$176	Sell	50 -1	-2%	-$3	﹤0.01%	696
2023 Q3	$341	Hold	51	–	–	﹤0.01%	683
2023 Q2	$428	Buy	51 +27	+113%	+$266	﹤0.01%	697
2023 Q1	$238	Buy	24 +1	+4%	+$7	﹤0.01%	711
2022 Q4	$160	Hold	23	–	–	﹤0.01%	703
2022 Q3	$0	Hold	23	–	–	﹤0.01%	698
2022 Q2	$0	Hold	23	–	–	﹤0.01%	718
2022 Q1	$0	Sell	23 -1	-4%	-$4	﹤0.01%	761
2021 Q4	$0	Hold	24	–	–	﹤0.01%	792
2021 Q3	$0	Sell	24 -17	-41%	-$156	﹤0.01%	904
2021 Q2	$0	Buy	+41	New	+$493	﹤0.01%	943

Other funds holding ALDX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Institutional & Family Asset Management's ALDX Position: Q2 2024 in Review

Institutional & Family Asset Management held its Aldeyra Therapeutics (ALDX) position steady in Q2 2024 at 50 shares worth $166. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Institutional & Family Asset Management first reported a position in ALDX in Q2 2021 and has held it in 13 quarters since. The position peaked at $428 in Q2 2023. 103 funds tracked by Wall St. Rank hold ALDX as of Q2 2024.

Institutional & Family Asset Management held 50 shares of Aldeyra Therapeutics worth $166 as of Q2 2024.
Institutional & Family Asset Management left its Aldeyra Therapeutics share count unchanged in Q2 2024.
Aldeyra Therapeutics made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #732 holding.
Institutional & Family Asset Management first reported a position in Aldeyra Therapeutics in Q2 2021 and has held it in 13 quarters since.
Institutional & Family Asset Management's Aldeyra Therapeutics position peaked at $428 in Q2 2023.
103 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.